Since 2013, CU Medicine has been conducting research on faecal microbiota transplantation (FMT) in patients with recurrent CDI and other diseases at the Prince of Wales Hospital. To date, it has performed over 800 FMT procedures. In 2020, the Microbiota I-Center (MagIC) of CU Medicine, funded by the InnoHK initiative of the Hong Kong government, developed a novel technology, MOZAIC™️, to improve the clinical outcome of FMT. The success rate is over 90% in patients with recurrent CDI. In addition, patients’ median survival doubled from 2.1 to 4.7 years.
At the launch ceremony today, CU Medicine officially announced that MOZAIC™️ has been adopted by the local health authority, the Hospital Authority, to provide a territory wide FMT service to patients in public hospitals in Hong Kong.
Professor Sun Dong, Secretary for Innovation, Technology and Industry, Hong Kong government, delivers the speech for the opening ceremony (Photos: CUHK).
Mr Henry Fan, Chairman of HA, delivers the speech for the opening ceremony (Photos: CUHK).
Professor Francis Chan addressed the partnership between CU Medicine and HA serves as a successful example of how innovations can be translated into clinical application, and demonstrates the immense potential of gut microbiota in curing diseases and saving lives (Photo: CUHK).
Professor Siew Ng introduced the MOZAIC™ technology with FMT into capsules for benefiting patients with CDI in Hong Kong and the Greater Bay Area (Photo: CUHK).
Guests at the ceremony taking a group photo (Photo: ORKTS)
Guests at the ceremony taking a group photo (Photo: ORKTS)
Guests at the ceremony taking a group photo (Photo: ORKTS)
Guests at the ceremony taking a group photo (Photo: CUHK)
